Hepatitis: all 3,372 studies
Page 25 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)Status unknownNCT01589952Phase 1/2
- Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With EntecavirStatus unknownNCT01588912Phase 4
- Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 InfectionCompletedNCT01587586Phase 2
- A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected PatientsTerminatedNCT01586325Phase 1
- Study to Examine Multiple Doses of TMC647055 in Combination With TelaprevirCompletedNCT01582035Phase 1
- Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C PatientsCompletedNCT01581398Phase 3
- Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)CompletedNCT01581203Phase 3
- VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis CCompletedNCT01581138Phase 2
- Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus LamivudineCompletedNCT01580202Phase 3
- A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor TreatmentWithdrawnNCT01579019Phase 2
- Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With TelaprevirCompletedNCT01577069
- Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV)CompletedNCT01574521
- Effects of Activity and Education Program on Patients With Chronic Hepatitis C InfectionStatus unknownNCT01572233Not applicable
- Coffee Effect in HCV-related HepatitisCompletedNCT01572103Phase 3
- An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver TransplantationCompletedNCT01571583Phase 3
- A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected PatientsCompletedNCT01567735Phase 3
- Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV InfectionTerminatedNCT01560468Phase 1
- A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002)TerminatedNCT01554189Phase 1
- First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1TerminatedNCT01554085Phase 1
- Resistance to Lamivudine in HBV Egyptian PatientsCompletedNCT01548820
- Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B VaccineStatus unknownNCT01548326Phase 4
- Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022)WithdrawnNCT01547312Phase 1
- Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)Status unknownNCT01545544
- Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHBCompletedNCT01532843Phase 4
- A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated InterferonCompletedNCT01531166
- EFFORT Extension StudyStatus unknownNCT01529255Phase 4
- Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical TrialCompletedNCT01525810
- Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected PatientsWithdrawnNCT01525212Phase 1
- A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected PatientsCompletedNCT01523990Phase 1
- Tenofovir in Chronic Hepatitis B With Mild ALT ElevationCompletedNCT01522625Phase 4
- Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted PatientsTerminatedNCT01518933Phase 2
- 24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS CWithdrawnNCT01517308Phase 3
- A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated CirrhosisCompletedNCT01516918Phase 2
- An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)CompletedNCT01513941Phase 3
- Keyhole Limpet Hemocyanin in Chronic Hepatitis CCompletedNCT01509391Not applicable
- Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C SubjectsNo longer availableNCT01508286
- Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)CompletedNCT01508156Phase 1/2
- Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective StudyCompletedNCT01502397
- Telaprevir Open-Label Study in Co-Infected PatientsCompletedNCT01500616Phase 3
- Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B VirusCompletedNCT01500265
- A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) PatientsCompletedNCT01497834Phase 3
- Open-Label Hepatic Impairment StudyCompletedNCT01497327Phase 1
- Role of FXR in Hepatitis C Virus ReplicationTerminatedNCT01492998Not applicable
- Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical TrialCompletedNCT01492504
- Psychobiological Characterization of Depression in Hepatitis CStatus unknownNCT01492478
- Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsStatus unknownNCT01491295Phase 4
- Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01488526Phase 4
- Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B PatientsStatus unknownNCT01487876Phase 2
- A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive OvysmenCompletedNCT01486004Phase 1
- A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated CirrhosisCompletedNCT01483742Phase 2
- A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382CompletedNCT01482611Phase 1
- A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis CCompletedNCT01482403Phase 2
- A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis CCompletedNCT01482390Phase 2
- Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) ExposureCompletedNCT01481649
- Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese SubjectsCompletedNCT01480622Phase 1
- Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) InfectionCompletedNCT01480492Not applicable
- A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and TacrolimusCompletedNCT01479881Phase 1
- Prognostic Indicators as Provided by the EPIC ClearViewCompletedNCT01476995
- HCV-TARGET- Hepatitis C Therapeutic Registry and Research NetworkCompletedNCT01474811
- Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant RecipientsStatus unknownNCT01473849
- Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected SubjectsCompletedNCT01473056Phase 1
- Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected AdultsCompletedNCT01472354Not applicable
- HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon TreatedCompletedNCT01471535Not applicable
- Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft RecipientsCompletedNCT01469884Phase 4
- Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis CTerminatedNCT01465919Phase 4
- Treating Hispanic Patients Diagnosed With Hepatitis C Using BoceprevirTerminatedNCT01465516
- The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis CCompletedNCT01464008
- To Study the Efficacy and Safety of Renessans in Chronic HCV PatientsStatus unknownNCT01463592Phase 3
- Cohort of Hepatitis B Research of AmsterdamStatus unknownNCT01462981
- Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C SubjectsStatus unknownNCT01459419Phase 2
- WEUSKOP5410: Observational Study in ENABLE Clinical TrialsCompletedNCT01458080
- Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)Status unknownNCT01457937Phase 3
- A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic ResponseCompletedNCT01457768
- Gilead Sustained Virologic Response (SVR) RegistryCompletedNCT01457755
- HBsAg Related Response Guided TherapyStatus unknownNCT01456312Phase 4
- Short-term Survival in Patients With Severe Alcoholic Hepatitis Treated With Steroid Versus PentoxifyllineStatus unknownNCT01455337Phase 3
- Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available MedicationsCompletedNCT01455090Phase 2
- Pharmacogenomic Research in Korean Patients With Hepatitis CCompletedNCT01453244
- Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-respondersStatus unknownNCT01451801Phase 4
- Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)CompletedNCT01448915
- A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1CompletedNCT01448200Phase 1
- Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody TestingCompletedNCT01447680
- Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis CWithdrawnNCT01447394Phase 3
- Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating DrugsStatus unknownNCT01446978Phase 2
- Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve SubjectsCompletedNCT01445795Phase 1/2
- Directly Observed Hepatitis C Treatment in Methadone ClinicsCompletedNCT01442311Not applicable
- A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC PolymorphismStatus unknownNCT01441804Phase 3
- Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B VaccinationStatus unknownNCT01441609
- Add Vitamin D With Standard of Care for Chronic Hepatitis C PatientsCompletedNCT01439776Phase 4
- Q-Trial in Patients With Hepatitis CCompletedNCT01438320Phase 1
- Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B PatientsStatus unknownNCT01436539Phase 4
- GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) InfectionCompletedNCT01435226Phase 2
- Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C InfectionCompletedNCT01435044Phase 2
- Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon TherapyStatus unknownNCT01434212
- Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6CompletedNCT01433887Phase 3
- Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV PatientsTerminatedNCT01433133Phase 1/2
- Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT01431898Phase 1
- Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure BiopumpWithdrawnNCT01430000Phase 1/2
- Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 BCompletedNCT01429155
- Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)Status unknownNCT01426204